News and Events

Series B Investment of CHF 16 Million

July 5th, 2011 - MyoPowers Closes Series B Investment of CHF 16 Million. Truffle Capital Leads Round, Joining Novartis Venture Funds and other Series A Investors to bring Artificial Sphincter Technology to Market
  

MyoPowers Receives ISO 13485 QMS Certification

March 8th, 2011 - LAUSANNE, SWITZERLAND - March 8, 2011: MyoPowers Received ISO 13485:2003 Certification of its Quality Management System (ISO 13485:2003 Quality Management System Certification Underscores Medical Device Startup’s Commitment to Quality Performance).

Third prize for the best abstract

September 9th, 2009 - The abstract called ‘New concept of artificial muscle for urinary incontinence treatment’ by M. Valerio, P. Jichlinski, M. Wieland, P.-A. Conus, P. Thevenaz, F. Salchli, P. Tozzi and A.R. Mundy has been nominated for third prize for the best abstract at the European Association of Urology (EAU) congress in Barcelona (16.-20. April 2010).

Pages